Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023

$ 14.00

5
(467)
In stock
Description

This report describes measures that people who are immunocompromised can take to prevent and treat COVID-19.

FDA Pulls Evusheld Authorization for Preventing COVID

Antibodies that neutralize all current SARS-CoV-2 variants of

Impact of COVID-19 on immunocompromised populations during the

Download Social distancing made easy, anime memes face

Efficacy of COVID-19 Vaccines against the Omicron Variant of SARS

Nonhospitalized Adults: Therapeutic Management

February 2, 2023 Parasites without Borders

Airway and Oral microbiome profiling of SARS-CoV-2 infected asthma

Frontiers The Immune Response and Immunopathology of COVID-19

BARDA Industry Day 2021: November 4, 2021 Virtual Event, 43% OFF

The evolution of SARS-CoV-2 Nature Reviews Microbiology